This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Zanamivir as prophylaxis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

A double-blind placebo controlled study of inhaled Zanamivir for the treatment and prevention of influenza in families had a 79% efficacy in preventing secondary cases when drug was given for 10 days to all exposed family members.


  • 1) Hayden FG et al (2000). Inhaled Zanamivir for the prevention of influenza in families. NEJM, 343(18), 1282-1289.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page